{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,13]],"date-time":"2026-10-13T22:01:59Z","timestamp":1791928919597,"version":"4.3.4"},"reference-count":108,"publisher":"Association for Research in Vision and Ophthalmology (ARVO)","issue":"11","license":[{"start":{"date-parts":[[2025,8,27]],"date-time":"2025-08-27T00:00:00Z","timestamp":1756252800000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Invest. Ophthalmol. Vis. Sci."],"published-print":{"date-parts":[[2025,8,27]]},"DOI":"10.1167\/iovs.66.11.45","type":"journal-article","created":{"date-parts":[[2025,8,20]],"date-time":"2025-08-20T14:30:41Z","timestamp":1755700241000},"page":"45","source":"Crossref","is-referenced-by-count":0,"title":["Mathematical Models of Topically and Intravitreally Applied Ranibizumab"],"prefix":"10.1167","volume":"66","author":[{"given":"Paul A.","family":"Roberts","sequence":"first","affiliation":[{"name":"Centre for Systems Modelling and Quantitative Biomedicine, University of Birmingham, Birmingham, United Kingdom"},{"name":"Department of Optometry and Visual Sciences, City St George\u2019s, University of London, London, United Kingdom"},{"name":"https:\/\/orcid.org\/0000-0001-5293-6431"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chloe N.","family":"Thomas","sequence":"additional","affiliation":[{"name":"Department of Biomedical Sciences, University of Birmingham, Birmingham, United Kingdom"},{"name":"https:\/\/orcid.org\/0000-0002-6202-1347"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gabriel","family":"Bellamy Plaice","sequence":"additional","affiliation":[{"name":"Department of Biomedical Sciences, University of Birmingham, Birmingham, United Kingdom"},{"name":"https:\/\/orcid.org\/0009-0001-5184-193X"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"James A.","family":"Roberts","sequence":"additional","affiliation":[{"name":"Department of Biomedical Sciences, University of Birmingham, Birmingham, United Kingdom"},{"name":"https:\/\/orcid.org\/0000-0001-5253-9700"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marie-Christine","family":"Jones","sequence":"additional","affiliation":[{"name":"School of Pharmacy, University of Birmingham, Birmingham, United Kingdom"},{"name":"https:\/\/orcid.org\/0000-0002-5662-1565"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"James W.","family":"Andrews","sequence":"additional","affiliation":[{"name":"School of Mathematics, University of Birmingham, Birmingham, United Kingdom"},{"name":"https:\/\/orcid.org\/0000-0002-4003-7487"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lisa J.","family":"Hill","sequence":"additional","affiliation":[{"name":"Department of Biomedical Sciences, University of Birmingham, Birmingham, United Kingdom"},{"name":"Birmingham Biomedical Research Centre, National Institute for Health and Care Research, University Hospitals Birmingham, Birmingham, United Kingdom"},{"name":"https:\/\/orcid.org\/0000-0001-8431-7029"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"27","reference":[{"issue":"2","key":"bib1","doi-asserted-by":"publisher","first-page":"e106","DOI":"10.1016\/S2214-109X(13)70145-1","article-title":"Global prevalence of age-related macular degeneration and disease burden projection for 2020 and 2040: a systematic review and meta-analysis","volume":"2","author":"Wong","year":"2024","journal-title":"Lancet Glob Health"},{"issue":"4","key":"bib2","doi-asserted-by":"publisher","first-page":"844","DOI":"10.1016\/j.ophtha.2012.10.036","article-title":"Clinical classification of age-related macular degeneration","volume":"120","author":"Ferris","year":"2013","journal-title":"Ophthalmology"},{"issue":"9652","key":"bib3","doi-asserted-by":"publisher","first-page":"1835","DOI":"10.1016\/S0140-6736(08)61759-6","article-title":"Age-related macular degeneration","volume":"372","author":"Coleman","year":"2008","journal-title":"Lancet"},{"issue":"24","key":"bib4","doi-asserted-by":"publisher","first-page":"2606","DOI":"10.1056\/NEJMra0801537","article-title":"Age-related macular degeneration","volume":"358","author":"Jager","year":"2008","journal-title":"N Engl J Med."},{"key":"bib5","doi-asserted-by":"publisher","first-page":"1363","DOI":"10.3389\/fphar.2019.01363","article-title":"Choroidal neovascularization: mechanisms of endothelial dysfunction","volume":"10","author":"Yeo","year":"2019","journal-title":"Front Pharmacol."},{"issue":"8","key":"bib6","doi-asserted-by":"publisher","first-page":"365","DOI":"10.3390\/pharmaceutics11080365","article-title":"Pharmacokinetics of intravitreal anti-VEGF drugs in age-related macular degeneration","volume":"11","author":"Garc\u00eda-Quintanilla","year":"2019","journal-title":"Pharmaceutics"},{"issue":"7","key":"bib7","doi-asserted-by":"publisher","first-page":"787","DOI":"10.1038\/eye.2013.107","article-title":"Adverse events and complications associated with intravitreal injection of anti-VEGF agents: a review of literature","volume":"27","author":"Ghasemi Falavarjani","year":"2013","journal-title":"Eye"},{"key":"bib8","doi-asserted-by":"publisher","first-page":"1167","DOI":"10.3762\/bjnano.13.98","article-title":"Microneedle-based ocular drug delivery systems - recent advances and challenges","volume":"13","author":"Gadzinski","year":"2022","journal-title":"Beilstein J Nanotechnol."},{"issue":"5","key":"bib9","doi-asserted-by":"publisher","first-page":"2578","DOI":"10.1167\/iovs.16-20072","article-title":"Topical delivery of anti-VEGF drugs to the ocular posterior segment using cell-penetrating peptides","volume":"58","author":"de Cogan","year":"2017","journal-title":"Invest Ophthalmol Vis Sci."},{"key":"bib10","doi-asserted-by":"publisher","first-page":"119285","DOI":"10.1016\/j.biomaterials.2019.119285","article-title":"Topical sustained drug delivery to the retina with a drug-eluting contact lens","volume":"217","author":"Ross","year":"2019","journal-title":"Biomaterials"},{"issue":"1","key":"bib11","doi-asserted-by":"publisher","first-page":"134","DOI":"10.3390\/pharmaceutics14010134","article-title":"Topical drug delivery to the posterior segment of the eye","volume":"14","author":"L\u00f6scher","year":"2022","journal-title":"Pharmaceutics"},{"issue":"30","key":"bib12","doi-asserted-by":"publisher","first-page":"18188","DOI":"10.1074\/jbc.271.30.18188","article-title":"Cell internalization of the third helix of the antennapedia homeodomain is receptor-independent","volume":"271","author":"Derossi","year":"1996","journal-title":"J Biol Chem."},{"issue":"4","key":"bib13","doi-asserted-by":"publisher","first-page":"2437","DOI":"10.1074\/jbc.M110017200","article-title":"Possible existence of common internalization mechanisms among arginine-rich peptides","volume":"277","author":"Suzuki","year":"2002","journal-title":"J Biol Chem."},{"issue":"1","key":"bib14","doi-asserted-by":"publisher","first-page":"107","DOI":"10.1038\/sj.mt.6300324","article-title":"Cell-penetrating peptide for enhanced delivery of nucleic acids and drugs to ocular tissues including retina and cornea","volume":"16","author":"Johnson","year":"2008","journal-title":"Mol Ther."},{"issue":"11","key":"bib15","doi-asserted-by":"publisher","first-page":"1253","DOI":"10.1038\/81359","article-title":"Conjugation of arginine oligomers to cyclosporin A facilitates topical delivery and inhibition of inflammation","volume":"6","author":"Rothbard","year":"2000","journal-title":"Nat Med."},{"issue":"25","key":"bib16","doi-asserted-by":"publisher","first-page":"16010","DOI":"10.1074\/jbc.272.25.16010","article-title":"A truncated HIV-1 tat protein basic domain rapidly translocates through the plasma membrane and accumulates in the cell nucleus","volume":"272","author":"Viv\u00e8s","year":"1997","journal-title":"J Biol Chem."},{"issue":"9","key":"bib17","doi-asserted-by":"publisher","first-page":"2941","DOI":"10.1021\/acs.molpharmaceut.5b00849","article-title":"A mechanistic model of the intravitreal pharmacokinetics of large molecules and the pharmacodynamic suppression of ocular vascular endothelial growth factor levels by ranibizumab in patients with neovascular age-related macular degeneration","volume":"13","author":"Hutton-Smith","year":"2016","journal-title":"Mol Pharm."},{"issue":"8","key":"bib18","doi-asserted-by":"publisher","first-page":"2690","DOI":"10.1021\/acs.molpharmaceut.7b00164","article-title":"Ocular pharmacokinetics of therapeutic antibodies given by intravitreal injection: estimation of retinal permeabilities using a 3-compartment semi-mechanistic model","volume":"14","author":"Hutton-Smith","year":"2017","journal-title":"Mol Pharm."},{"issue":"7","key":"bib19","doi-asserted-by":"publisher","first-page":"2770","DOI":"10.1021\/acs.molpharmaceut.8b00280","article-title":"Theoretical insights into the retinal dynamics of vascular endothelial growth factor in patients treated with ranibizumab, based on an ocular pharmacokinetic\/pharmacodynamic model","volume":"15","author":"Hutton-Smith","year":"2018","journal-title":"Mol Pharm."},{"issue":"8","key":"bib20","doi-asserted-by":"publisher","first-page":"1939","DOI":"10.1007\/s11095-023-03560-7","article-title":"A physiology-based mathematical model to understand drug delivery from contact lenses to the back of the eye","volume":"40","author":"Toffoletto","year":"2023","journal-title":"Pharm Res."},{"issue":"5","key":"bib21","doi-asserted-by":"publisher","first-page":"1049","DOI":"10.1007\/s11095-010-0356-7","article-title":"Contribution of saccadic motion to intravitreal drug transport: theoretical analysis","volume":"28","author":"Balachandran","year":"2011","journal-title":"Pharm Res."},{"issue":"6","key":"bib22","doi-asserted-by":"publisher","first-page":"1969","DOI":"10.1088\/0031-9155\/58\/6\/1969","article-title":"Investigation of the motion of a viscous fluid in the vitreous cavity induced by eye rotations and implications for drug delivery","volume":"58","author":"Bonfiglio","year":"2013","journal-title":"Phys Med Biol."},{"key":"bib23","doi-asserted-by":"publisher","first-page":"49","DOI":"10.1016\/j.medengphy.2020.06.005","article-title":"A drug delivery analysis of large molecules in ocular vitreous chamber: dependency on saccadic movements after intravitreal injection","volume":"82","author":"Ferroni","year":"2020","journal-title":"Med Eng Phys."},{"issue":"12","key":"bib24","doi-asserted-by":"publisher","first-page":"3251","DOI":"10.1007\/s11095-012-0721-9","article-title":"Simulating intravitreal injections in anatomically accurate models for rabbit, monkey, and human eyes","volume":"29","author":"Missel","year":"2012","journal-title":"Pharm Res."},{"issue":"4","key":"bib25","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1167\/iovs.65.4.9","article-title":"Drug distribution after intravitreal injection: a mathematical model","volume":"65","author":"Ruffni","year":"2024","journal-title":"Invest Ophthalmol Vis Sci."},{"issue":"2","key":"bib26","doi-asserted-by":"publisher","first-page":"453","DOI":"10.1088\/0031-9155\/55\/2\/008","article-title":"Mixing processes in the vitreous chamber induced by eye rotations","volume":"55","author":"Stocchino","year":"2010","journal-title":"Phys Med Biol."},{"issue":"12","key":"bib27","doi-asserted-by":"publisher","first-page":"2003","DOI":"10.1007\/s11095-021-03141-6","article-title":"Ocular fluid mechanics and drug delivery: a review of mathematical and computational models","volume":"38","author":"Bhandari","year":"2021","journal-title":"Pharm Res."},{"key":"bib28","doi-asserted-by":"publisher","first-page":"134","DOI":"10.1016\/j.preteyeres.2016.12.001","article-title":"Pharmacokinetic aspects of retinal drug delivery","volume":"57","author":"del Amo","year":"2017","journal-title":"Prog Retin Eye Res."},{"issue":"2","key":"bib29","doi-asserted-by":"publisher","first-page":"022002","DOI":"10.1088\/2516-1091\/acc8a9","article-title":"Advancing treatment of retinal disease through in silico trials","volume":"5","author":"Hernandez","year":"2023","journal-title":"Prog Biomed Eng."},{"issue":"11","key":"bib30","doi-asserted-by":"publisher","first-page":"28","DOI":"10.1167\/iovs.65.11.28","article-title":"Mathematical models of ocular drug delivery","volume":"65","author":"Sadeghi","year":"2024","journal-title":"Invest Ophthalmol Vis Sci."},{"key":"bib31","doi-asserted-by":"publisher","first-page":"48","DOI":"10.1016\/j.preteyeres.2016.04.001","article-title":"Mathematical and computational models of the retina in health, development and disease","volume":"53","author":"Roberts","year":"2016","journal-title":"Prog Retin Eye Res."},{"key":"bib32","doi-asserted-by":"publisher","first-page":"35","DOI":"10.2147\/IJN.S428684","article-title":"Topical application of cellpenetrating peptide modified anti-VEGF drug alleviated choroidal neovascularization in mice","volume":"19","author":"Hu","year":"2024","journal-title":"Int J Nanomed"},{"issue":"10","key":"bib33","doi-asserted-by":"publisher","first-page":"1107","DOI":"10.1038\/nm1010-1107","article-title":"Vascular endothelial growth factor and age-related macular degeneration: from basic science to therapy","volume":"16","author":"Ferrara","year":"2010","journal-title":"Nat Med."},{"issue":"8","key":"bib34","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1371\/journal.pone.0221481","article-title":"Evaluation of vascular endothelial growth factor levels in tears and serum among diabetic patients","volume":"14","author":"Ang","year":"2019","journal-title":"PLoS One"},{"issue":"1","key":"bib35","doi-asserted-by":"publisher","first-page":"573681","DOI":"10.1155\/2015\/573681","article-title":"Vascular endothelial growth factor in tear samples of patients with systemic sclerosis","volume":"2015","author":"Rentka","year":"2015","journal-title":"Mediators Inflamm"},{"issue":"1","key":"bib36","doi-asserted-by":"publisher","first-page":"4423","DOI":"10.1038\/s41598-022-08492-7","article-title":"Evaluation of vascular endothelial growth factor (VEGF) level in the tears and serum of age-related macular degeneration patients","volume":"12","author":"Shahidatul-Adha","year":"2022","journal-title":"Sci Rep."},{"key":"bib38","doi-asserted-by":"publisher","first-page":"100845","DOI":"10.1016\/j.preteyeres.2020.100845","article-title":"No flow through the vitreous humor: how strong is the evidence?","volume":"78","author":"Smith","year":"2020","journal-title":"Prog Retin Eye Res."},{"issue":"3","key":"bib40","doi-asserted-by":"publisher","first-page":"348","DOI":"10.1208\/s12248-010-9183-3","article-title":"Ocular drug delivery","volume":"12","author":"Gaudana","year":"2010","journal-title":"AAPS J"},{"key":"bib41","doi-asserted-by":"publisher","first-page":"102342","DOI":"10.1016\/j.cis.2020.102342","article-title":"Strategies to prolong the residence time of drug delivery systems on ocular surface","volume":"288","author":"Grassiri","year":"2021","journal-title":"Adv Colloid Interface Sci."},{"key":"bib42","doi-asserted-by":"publisher","first-page":"120924","DOI":"10.1016\/j.ijpharm.2021.120924","article-title":"Drug delivery to the anterior segment of the eye: a review of current and future treatment strategies","volume":"607","author":"Mofidfar","year":"2021","journal-title":"Int J Pharm."},{"issue":"8","key":"bib43","doi-asserted-by":"publisher","first-page":"1446","DOI":"10.1016\/j.drudis.2019.02.001","article-title":"Design principles of ocular drug delivery systems: importance of drug payload, release rate, and material properties","volume":"24","author":"Subrizi","year":"2019","journal-title":"Drug Discov Today"},{"issue":"3","key":"bib44","first-page":"264","article-title":"Determination of tear volume and tear flow","volume":"5","author":"Mishima","year":"1966","journal-title":"Invest Ophthalmol Vis Sci."},{"issue":"2","key":"bib45","doi-asserted-by":"publisher","first-page":"141","DOI":"10.1007\/BF00410700","article-title":"Tear volume in normal eyes and keratoconjunctivitissicca","volume":"192","author":"Scherz","year":"1974","journal-title":"Albrecht von Graefes Arch Klin Ophthal."},{"issue":"6","key":"bib46","doi-asserted-by":"publisher","first-page":"735","DOI":"10.1007\/s13346-016-0339-2","article-title":"A comprehensive insight on ocular pharmacokinetics","volume":"6","author":"Agrahari","year":"2016","journal-title":"Drug Deliv Transl Res."},{"issue":"4","key":"bib47","first-page":"504","article-title":"Clinical pharmacokinetics of the eye. Proctor lecture","volume":"21","author":"Mishima","year":"1981","journal-title":"Invest Ophthalmol Vis Sci."},{"issue":"4","key":"bib48","doi-asserted-by":"publisher","first-page":"407","DOI":"10.1016\/S0002-9394(98)00436-X","article-title":"Aqueous humor dynamics in the aging human eye","volume":"127","author":"Toris","year":"1999","journal-title":"Am J Ophthalmol."},{"issue":"4","key":"bib49","doi-asserted-by":"publisher","first-page":"403","DOI":"10.1177\/0192623318770379","article-title":"G\u00f6ttingen minipigs in ocular research","volume":"46","author":"Shrader","year":"2018","journal-title":"Toxicol Pathol."},{"issue":"4","key":"bib51","doi-asserted-by":"publisher","first-page":"508","DOI":"10.1016\/j.ajo.2008.05.036","article-title":"Intraocular pharmacokinetics of bevacizumab after a single intravitreal injection in humans","volume":"146","author":"Krohne","year":"2008","journal-title":"Am J Ophthalmol."},{"issue":"10","key":"bib52","doi-asserted-by":"publisher","first-page":"1750","DOI":"10.1016\/j.ophtha.2008.04.023","article-title":"Vitreous levels of bevacizumab and vascular endothelial growth factor-A in patients with choroidal neovascularization","volume":"115","author":"Zhu","year":"2008","journal-title":"Ophthalmology"},{"issue":"3","key":"bib54","doi-asserted-by":"publisher","first-page":"193","DOI":"10.1111\/j.1463-5224.2008.00619.x","article-title":"Experimental determination and allometric prediction of vitreous volume, and retina and lens weights in G\u00f6ttingen minipigs","volume":"11","author":"Shafiee","year":"2008","journal-title":"Vet Ophthalmol."},{"issue":"3","key":"bib56","doi-asserted-by":"publisher","first-page":"259","DOI":"10.1097\/01.ico.0000148312.01805.53","article-title":"White-to-white corneal diameter: normal values in healthy humans obtained with the orbscan II topography system","volume":"24","author":"R\u00fcfer","year":"2005","journal-title":"Cornea"},{"issue":"8","key":"bib57","first-page":"2529","article-title":"Porcine sclera: thickness and surface area","volume":"43","author":"Olsen","year":"2002","journal-title":"Invest Ophthalmol Vis Sci."},{"issue":"7","key":"bib58","doi-asserted-by":"publisher","first-page":"3260","DOI":"10.1167\/iovs.06-1376","article-title":"Optomechanical response of human and monkey lenses in a lens stretcher","volume":"48","author":"F.Manns","year":"2007","journal-title":"Invest Ophthalmol Vis Sci."},{"issue":"2","key":"bib59","doi-asserted-by":"publisher","first-page":"024002","DOI":"10.1117\/1.2907453","article-title":"Optical coherence tomography measurements of the fresh porcine eye and response of the outer coats of the eye to volume increase","volume":"13","author":"Asejczyk-Widlicka","year":"2008","journal-title":"J Biomed Opt."},{"issue":"9","key":"bib60","doi-asserted-by":"publisher","first-page":"942","DOI":"10.2460\/ajvr.1997.58.09.942","article-title":"Ultrasound biomicroscopy of globes from young adult pigs","volume":"58","author":"Bartholomew","year":"1997","journal-title":"Am J Vet Res."},{"issue":"9","key":"bib61","doi-asserted-by":"publisher","first-page":"5332","DOI":"10.1167\/iovs.14-16185","article-title":"Measurement of ex vivo porcine lens shape during simulated accommodation, before and after fs-laser treatment","volume":"56","author":"Hahn","year":"2015","journal-title":"Invest Ophthalmol Vis Sci."},{"issue":"3","key":"bib62","doi-asserted-by":"publisher","first-page":"483","DOI":"10.1016\/j.exer.2008.10.021","article-title":"Comparison of the behavior of natural and refilled porcine lenses in a robotic lens stretcher","volume":"88","author":"Reilly","year":"2009","journal-title":"Exp Eye Res."},{"issue":"4","key":"bib63","doi-asserted-by":"publisher","first-page":"475","DOI":"10.1007\/s00417-011-1617-9","article-title":"The parameters of the porcine eyeball","volume":"249","author":"Sanchez","year":"2011","journal-title":"Graefes Arch Clin Exp Ophthal."},{"issue":"4","key":"bib64","doi-asserted-by":"publisher","first-page":"8","DOI":"10.1167\/tvst.4.4.8","article-title":"Simulations of porcine eye exposure to primary blast insult","volume":"4","author":"Watson","year":"2015","journal-title":"Transl Vis Sci Technol."},{"issue":"2","key":"bib66","doi-asserted-by":"publisher","first-page":"171","DOI":"10.1007\/s10456-011-9249-6","article-title":"Binding and neutralization of vascular endothelial growth factor (VEGF) and related ligands by VEGF trap, ranibizumab and bevacizumab","volume":"15","author":"Papadopoulos","year":"2012","journal-title":"Angiogenesis"},{"issue":"8","key":"bib67","doi-asserted-by":"publisher","first-page":"859","DOI":"10.1097\/01.iae.0000242842.14624.e7","article-title":"Development of ranibizumab, an antivascular endothelial growth factor antigen binding fragment, as therapy for neovascular age-related macular degeneration","volume":"26","author":"Ferrara","year":"2006","journal-title":"Retina"},{"issue":"4","key":"bib68","doi-asserted-by":"publisher","first-page":"331","DOI":"10.1016\/j.preteyeres.2008.05.001","article-title":"Vascular endothelial growth factor in eye disease","volume":"27","author":"Penn","year":"2008","journal-title":"Prog Retin Eye Res."},{"issue":"4","key":"bib69","doi-asserted-by":"publisher","first-page":"641","DOI":"10.1016\/j.exer.2008.10.018","article-title":"Measurement of aqueous humor flow","volume":"88","author":"McLaren","year":"2009","journal-title":"Exp Eye Res."},{"issue":"9","key":"bib71","doi-asserted-by":"publisher","first-page":"8045","DOI":"10.3390\/ijms24098045","article-title":"Topical treatment for retinal degenerative pathologies: a systematic review","volume":"24","author":"Samoila","year":"2023","journal-title":"Int J Mol Sci."},{"issue":"6","key":"bib72","doi-asserted-by":"publisher","first-page":"3530","DOI":"10.1167\/iovs.10-6025","article-title":"Ocular surface health during 30-day continuous wear: rigid gas-permeable versus silicone hydrogel hyper-O2 transmitted contact lenses","volume":"52","author":"Lin","year":"2011","journal-title":"Invest Ophthalmol Vis Sci."},{"issue":"7","key":"bib73","doi-asserted-by":"publisher","first-page":"3346","DOI":"10.1167\/iovs.08-2826","article-title":"A drug-eluting contact lens","volume":"50","author":"Ciolino","year":"2009","journal-title":"Invest Ophthalmol Vis Sci."},{"key":"bib74","doi-asserted-by":"publisher","first-page":"1465","DOI":"10.2147\/OPTH.S409103","article-title":"Through the eyes of patients: understanding treatment burden of intravitreal anti-VEGF injections for nAMD patients in Norway","volume":"17","author":"Reitan","year":"2023","journal-title":"Clin Ophthalmol."},{"issue":"1","key":"bib75","doi-asserted-by":"publisher","first-page":"3301","DOI":"10.1038\/s41598-019-38934-8","article-title":"Anti-VEGF injection frequency correlates with visual acuity outcomes in pro re nata neovascular AMD treatment","volume":"9","author":"Wecker","year":"2019","journal-title":"Sci Rep."},{"issue":"10411","key":"bib76","doi-asserted-by":"publisher","first-page":"1396","DOI":"10.1016\/S0140-6736(23)01844-5","article-title":"Complement inhibitors for the treatment of geographic atrophy","volume":"402","author":"Chew","year":"2023","journal-title":"Lancet"},{"issue":"10411","key":"bib77","doi-asserted-by":"publisher","first-page":"1434","DOI":"10.1016\/S0140-6736(23)01520-9","article-title":"Pegcetacoplan for the treatment of geographic atrophy secondary to age-related macular degeneration (OAKS and DERBY): two multicentre, randomised, double-masked, sham-controlled, phase 3 trials","volume":"402","author":"Heier","year":"2023","journal-title":"Lancet"},{"issue":"10411","key":"bib78","doi-asserted-by":"publisher","first-page":"1449","DOI":"10.1016\/S0140-6736(23)01583-0","article-title":"Efficacy and safety of avacincaptad pegol in patients with geographic atrophy (GATHER2): 12-month results from a randomised, double-masked, phase 3 trial","volume":"402","author":"Khanani","year":"2023","journal-title":"Lancet"},{"issue":"5","key":"bib79","doi-asserted-by":"publisher","first-page":"989","DOI":"10.1016\/j.ajo.2013.06.020","article-title":"Long-term stability of vascular endothelial growth factor suppression time under ranibizumab treatment in age-related macular degeneration","volume":"156","author":"Muether","year":"2013","journal-title":"Am J Ophthalmol."},{"issue":"9","key":"bib80","doi-asserted-by":"publisher","first-page":"491","DOI":"10.1089\/jop.2019.0065","article-title":"Use of collagen binding domains to deliver molecules to the cornea","volume":"35","author":"Klarlund","year":"2019","journal-title":"J Ocul Pharmacol Ther."},{"issue":"8","key":"bib81","first-page":"5134","article-title":"Overcoming washout of biologics after topical application to the ocular surface","volume":"64","author":"Klarlund","year":"2023","journal-title":"Invest Ophthalmol Vis Sci"},{"issue":"22","key":"bib82","doi-asserted-by":"publisher","first-page":"1480","DOI":"10.1056\/NEJM199412013312203","article-title":"Vascular endothelial growth factor in ocular fluid of patients with diabetic retinopathy and other retinal disorders","volume":"331","author":"Aiello","year":"1994","journal-title":"N Engl J Med."},{"issue":"8","key":"bib83","doi-asserted-by":"publisher","first-page":"1575","DOI":"10.1002\/smll.201303433","article-title":"Topical delivery of avastin to the posterior segment of the eye in vivo using annexin A5-associated liposomes","volume":"10","author":"Davis","year":"2014","journal-title":"Small"},{"issue":"1","key":"bib84","doi-asserted-by":"publisher","first-page":"237","DOI":"10.1080\/10717544.2019.1574936","article-title":"Novel ophthalmic formulation of myriocin: implications in retinitis pigmentosa","volume":"26","author":"Platania","year":"2019","journal-title":"Drug Deliv."},{"issue":"248","key":"bib85","article-title":"Molecular features of interaction between VEGFA and anti-angiogenic drugs used in retinal diseases: a computational approach","volume":"6","author":"Platania","year":"2015","journal-title":"Front Pharmacol."},{"issue":"1","key":"bib86","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1002\/jps.2600770103","article-title":"Mechanisms of corneal drug penetration I: in vivo and in vitro kinetics","volume":"77","author":"Grass","year":"1988","journal-title":"J Pharm Sci."},{"issue":"6","key":"bib87","doi-asserted-by":"publisher","first-page":"1646","DOI":"10.3390\/pharmaceutics15061646","article-title":"Corneal permeability and uptake of twenty-five drugs: species comparison and quantitative structure-permeability relationships","volume":"15","author":"Santana","year":"2023","journal-title":"Pharmaceutics"},{"issue":"5","key":"bib88","doi-asserted-by":"publisher","first-page":"751","DOI":"10.1016\/S0014-4835(89)80036-3","article-title":"In vitro corneal endothelial permeability in rabbit and human: the effects of age, cataract surgery and diabetes","volume":"49","author":"Watsky","year":"1989","journal-title":"Exp Eye Res."},{"issue":"1","key":"bib90","doi-asserted-by":"publisher","first-page":"59","DOI":"10.1007\/s13318-016-0319-4","article-title":"Ocular drug distribution after topical administration: population pharmacokinetic model in rabbits","volume":"42","author":"Djebli","year":"2017","journal-title":"Eur J Drug Metab Pharmacokinet."},{"issue":"2","key":"bib91","doi-asserted-by":"publisher","first-page":"84","DOI":"10.1016\/0039-6257(81)90145-4","article-title":"Clinical biochemistry of tears","volume":"26","author":"Van Haeringen","year":"1981","journal-title":"Surv Ophthalmol."},{"issue":"10","key":"bib92","doi-asserted-by":"publisher","first-page":"1803","DOI":"10.1001\/archopht.1980.01020040655013","article-title":"Volume and depth of the anterior chamber in the normal aging human eye","volume":"98","author":"Fontana","year":"1980","journal-title":"Arch Ophthalmol."},{"key":"bib93","first-page":"125","article-title":"Topographic findings of the porcine cornea","volume":"5","author":"Heichel","year":"2016","journal-title":"Med Hypothesis Discov Innov Ophthalmol."},{"issue":"10","key":"bib94","doi-asserted-by":"publisher","first-page":"3421","DOI":"10.1021\/mp500160v","article-title":"Comparison of binding characteristics and in vitro activities of three inhibitors of vascular endothelial growth factor A","volume":"11","author":"Yang","year":"2014","journal-title":"Mol Pharm."},{"issue":"6018","key":"bib95","doi-asserted-by":"publisher","first-page":"764","DOI":"10.1126\/science.1199784","article-title":"Proteome half-life dynamics in living human cells","volume":"331","author":"Eden","year":"2011","journal-title":"Science"},{"key":"bib96","doi-asserted-by":"publisher","first-page":"e34202","DOI":"10.7554\/eLife.34202","article-title":"Local and global influences on protein turnover in neurons and glia","volume":"7","author":"D\u00f6rrbaum","year":"2018","journal-title":"eLife"},{"issue":"9","key":"bib98","doi-asserted-by":"publisher","first-page":"5390","DOI":"10.1167\/iovs.15-17108","article-title":"Design and pharmacokinetic characterization of novel antibody formats for ocular therapeutics","volume":"56","author":"Gadkar","year":"2015","journal-title":"Invest Ophthalmol Vis Sci."},{"issue":"10","key":"bib99","doi-asserted-by":"publisher","first-page":"2082","DOI":"10.1016\/j.ophtha.2012.07.041","article-title":"Vascular endothelial growth factor in patients with exudative age-related macular degeneration treated with ranibizumab","volume":"119","author":"Muether","year":"2012","journal-title":"Ophthalmology"},{"issue":"11","key":"bib100","doi-asserted-by":"publisher","first-page":"1554","DOI":"10.1136\/bjophthalmol-2015-306771","article-title":"A model of the ocular pharmacokinetics involved in the therapy of neovascular age-related macular degeneration with ranibizumab","volume":"99","author":"Saunders","year":"2015","journal-title":"Br J Ophthalmol."},{"key":"bib101","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.exer.2013.10.008","article-title":"Complexity of the tear film: importance in homeostasis and dysfunction during disease","volume":"117","author":"Dartt","year":"2013","journal-title":"Exp Eye Res."},{"issue":"4","key":"bib102","doi-asserted-by":"publisher","first-page":"564","DOI":"10.1111\/j.1755-3768.1979.tb00504.x","article-title":"Tear flow in normal human eyes. determination by means of radioisotope and gamma camera","volume":"57","author":"S\u00f8rensen","year":"1979","journal-title":"Acta Ophthalmol"},{"issue":"10","key":"bib103","doi-asserted-by":"publisher","first-page":"6403","DOI":"10.1167\/iovs.12-10367","article-title":"Intraocular VEGF level as a risk factor for postoperative complications after vitrectomy for proliferative diabetic retinopathy","volume":"53","author":"Wakabayashi","year":"2012","journal-title":"Invest Ophthalmol Vis Sci."},{"issue":"6","key":"bib104","doi-asserted-by":"crossref","first-page":"664","DOI":"10.1097\/CM9.0000000000000687","article-title":"Vascular endothelial growth factor concentration in vitreous humor of patients with severe proliferative diabetic retinopathy after intravitreal injection of conbercept as an adjunctive therapy for vitrectomy","volume":"133","author":"Li","year":"2020","journal-title":"Chin Med J."},{"key":"bib105","doi-asserted-by":"publisher","first-page":"1547","DOI":"10.2147\/OPTH.S248812","article-title":"Vitreous and serum concentrations of vascular endothelial growth factor and platelet-derived growth factor in proliferative diabetic retinopathy","volume":"14","author":"Muhiddin","year":"2020","journal-title":"Clin Ophthalmol."},{"issue":"6","key":"bib106","doi-asserted-by":"publisher","first-page":"2953","DOI":"10.1167\/iovs.08-2870","article-title":"Concentration gradient of vascular endothelial growth factor in the vitreous of eyes with diabetic macular edema","volume":"50","author":"Shimada","year":"2009","journal-title":"Invest Ophthalmol Vis Sci."},{"issue":"10","key":"bib107","first-page":"1","article-title":"Vitreous and plasma VEGF levels as predictive factors in the progression of proliferative diabetic retinopathy after vitrectomy","volume":"9","author":"Wang","year":"2014","journal-title":"PLoS One"},{"issue":"4","key":"bib108","doi-asserted-by":"publisher","first-page":"363","DOI":"10.1136\/bjo.80.4.363","article-title":"Levels of vascular endothelial growth factor are elevated in the vitreous of patients with subretinal neovascularisation","volume":"80","author":"Wells","year":"1996","journal-title":"Br J Ophthalmol."},{"key":"bib37","doi-asserted-by":"crossref","DOI":"10.1007\/b98868","volume-title":"Mathematical Biology: I. An Introduction","author":"Murray","year":"2002","edition":"3rd ed."},{"key":"bib39","article-title":"2020-2021 Basic and Clinical Science Course(tm) (BCSC), Section 02: fundamentals and Principles of Ophthalmology","volume-title":"Basic and Clinical Science Course","author":"Brar","year":"2020"},{"key":"bib50","article-title":"Assessing ocular toxicology in laboratory animals","volume-title":"Molecular and Integrative Toxicology, chapter Comparative Ocular Anatomy in Commonly Used Laboratory Animals","author":"V\u00e9zina","year":"2012"},{"key":"bib53","volume-title":"Blood and Other Body Fluids. Biological Handbooks","author":"Altman","year":"1961"},{"key":"bib55","volume-title":"Wolff's Anatomy of the Eye and Orbit","author":"Bron","year":"1997","edition":"8th ed."},{"key":"bib65"},{"key":"bib70","volume-title":"Duane's Ophthalmology","author":"Tasman","year":"2013"},{"key":"bib89","author":"Chang","year":"2024"},{"key":"bib97","volume-title":"Fundamentals of Biochemistry","author":"Jakubowski","year":"2024"}],"container-title":["Investigative Ophthalmology & Visual Science"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/iovs.arvojournals.org\/article.aspx?articleid=2810702","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,10,13]],"date-time":"2026-10-13T21:32:05Z","timestamp":1791927125000},"score":1,"resource":{"primary":{"URL":"https:\/\/iovs.arvojournals.org\/article.aspx?articleid=2810702"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,8,27]]},"references-count":108,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2025,8,1]]}},"URL":"https:\/\/doi.org\/10.1167\/iovs.66.11.45","relation":{},"ISSN":["1552-5783"],"issn-type":[{"value":"1552-5783","type":"print"}],"subject":[],"published":{"date-parts":[[2025,8,27]]}}}